FETCROJA 1 g, powder for concentrate for infusion 10 bottles of 14 ml
Active ingredients: Cefiderocol, Cefiderocol sulfate tosylate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for concentrate for infusion10 bottles of 14 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FETCROJA 1 g, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 14 ml
- Marketing authorisation holder
- SHIONOGI (PAYS BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Dec 2020
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64450362CIP75507549CIP133400955075493Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFIDÉROCOLpoudre | 1 g · un flacon | FT |
| TOSILATE DE SULFATE DE CÉFIDÉROCOLpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.